Ischemia-modified albumin in the era of high-sensitivity troponin immunoassays: useful or hype?

@article{Lippi2013IschemiamodifiedAI,
  title={Ischemia-modified albumin in the era of high-sensitivity troponin immunoassays: useful or hype?},
  author={Giuseppe Lippi and Gianfranco Cervellin and Mario Plebani},
  journal={Scandinavian journal of clinical and laboratory investigation},
  year={2013},
  volume={73 7},
  pages={598-9}
}
SIR: We read with interest the article of Sygitowicz et al., who concluded that ischemia-modifi ed albumin (IMA) may be a useful biomarker for identifying acute coronary syndrome (ACS) in patients presenting with typical acute chest pain and/or abnormal electrocardiograms, but negative value of cardiospecifi c troponin(s) [1]. It is noteworthy that these… CONTINUE READING